MBBS (Medicine), MHSc (Community Medicine), FRCPC (Community Medicine)

Jane Buxton is a professor and practicum director of the Masters of Public Health program in the School of Population and Public Health.

She works half time as physician epidemiologist at BC Centre for Disease Control (BCCDC) where she leads surveillance for hepatitis and bloodbourne pathogens and is medical lead for harm reduction.

Jane gained her medical degree in London (UK) and worked as a family physician for 7 years. She came to Canada and completed her Public Health and Preventive Medicine (formerly Community medicine) residency at UBC in 1999 and is a graduate of Health Canada federal field epidemiology program.

She is committed to undergraduate and post graduate student public health education. Over the past 10 years she has been primary supervisor for over a 100 students on placement at BCCDC (medical students, residents, MPH practicum students etc) where she shares her passion for public health and engages students in public health practice and applied public health research. She supervises MSc and PhD students in SPPH.

Her national postgraduate education roles include being on the Royal College examination board for Public Health and Preventive Medicine (PHPM) and in her 6th year as Chair of the Royal College PHPM Specialty Committee which oversees the standards of residency specialty training nationally.

Her research in illegal drug use epidemiology and harm reduction is recognized internationally and nationally. She developed the inter-sectoral Drug Overdose and Alert Partnership (DOAP) in 2011 to ensure timely identification of drug related harms and dissemination to those who need to know. She is engaged in quantitative, qualitative and participatory research with marginalized populations and believes people who use drugs should be involved in developing priorities for research, policy and harm reduction program evaluation. Jane co-chairs the BC Harm Reduction Strategies and Services and in August 2012 led the introduction of the BC overdose prevention and take-home-naloxone program.

Jane is the proud recipient of the 2014 Canadian Public Health Association Ron Draper Health Promotion Award which recognizes her national work related to take home naloxone. She received the 2012 James M. Robinson Award for significant contribution to public health awarded by SPPH and the 2013 BC Provincial Health Officer’s Award for Excellence in Public Health ‘for persistent and pioneering work to bring equitable harm reduction services and supplies to all of British Columbia.’

2014 Canadian Public Health Association Ron Draper Health Promotion Award 2013 Faculty of Medicine Killam Teaching Prize
2013 BC Provincial Health Officer’s Award for Excellence in Public Health
2012 James M. Robinson Award for significant contribution to public health
2008 CJG Mackenzie Prize for Excellence in Teaching

SELECTED PUBLICATIONS (from >150 peer reviewed articles)

Butt Z,  Shrestha N, Kuo M, Gesink D, Gilbert M, Wong J, Yu A, Alvarez M, Samji H, Buxton JA, et al.  A Syndemic Approach to Assess the Effect of Substance Use and Social disparities on the evolution of HIV/HCV infections in British Columbia PLOS ONE (2017)   http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0183609

Janssen PA, Korchinski M, , Demerais S, Albert AYK, Condello L, Bucghanan M, Granger-Brown A, Ramsden VR, Fels L, Buxton JA, Leggo C, Martin RE. Factors that support successful transition to community among women leaving prison in British Columbia: A Prospective Cohort Study. CMAJ Open (2017) 5(3) E717-723 http://cmajopen.ca/content/5/3/E717.full.pdf+html

Randall A, Buxton JA, Afshari R. Prevalence of allergies and food intolerance: A comparison between Canadians of Persian descent and Canadians of European descent.  Asia Pacific Journal of Medical Toxicology (2017)  http://apjmt.mums.ac.ir/article_9046_17445c2a6acf22edb6bf857582312f76.pdf

Nolan S, Buxton J, Dobrer S, Dong H, Hayashi K, Miloy MJ, Kerr T, Montaner J, Wood E. Awareness, possession and use of take home naloxone among illicit drug users Vancouver, British Columbia, 2014-2015.  Public Health Reports (2017) Online July 27

Mercer G, MacNab Y, Patrick D, Esser MM, Sun M, Buxton JA, Bettinger J. Exploring low levels of inter-parental agreement over South African fathers’ parenting practices. The Journal of Men’s Studies (2017) Published online

Mitchell K, Durante E, Pellatt K, Richardson CG, Mathias S, Buxton JA. Naloxone and the Inner City Youth Experience (NICYE): a community based participatory research study examining young peoples’ perceptions of the BC take home naloxone program. Harm Reduction Journal (2017) 14:34   http://rdcu.be/tiN6 (PI)


Islam N, Krajden M, Shoveller J, Gustafson P, Gilbert M, Buxton JA, Wong J, Tyndall M, Janjua NZ, BC-HTC Team. Incidence, risk factors and prevention of hepatitis C reinfection: A population-based cohort study. Lancet Gastroenterology and hepatology. Online (2016) DOI: http://dx.doi.org/10.1016/S2468-1253(16)30182-0

Crabtree A, Latham N, Bird L, Buxton J. Results of a participatory needs assessment demonstrate an opportunity to involve people who use alcohol in drug user activism and harm reduction Harm Reduction Journal (2016) 13:37 (PI) https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-016-0126-x

Martin RE, Turner R, Howett L, Howard T, Hanberg D, Buxton JA, Moravan V, Oliffe JL Twelve committed Men: the feasibility of a community-based participatory HIV-prevention intervention within a Canadian men’s correctional facility. Global Health Promotion (2016) Online http://ped.sagepub.com/cgi/reprint/1757975916659045v1.pdf?ijkey=9lL6sd2mlzQvKRo&keytype=finite

Taylor D, Ho A, Mâsse LC, Van Borek N, Li N; Patterson M, Ogilvie GS, Buxton JA. Assessment of capacity to consent by nurses who deliver health care to patients who misuse substances. Global Qualitative Nursing Research (2016) 3:1-9 http://gqn.sagepub.com/content/3/2333393616671076.full.pdf+html (PI)

Kestler A, Buxton JA, Meckling G, Giesler A, Lee M, Scheuermeyer F. Factors associated with participation in an emergency department-based take-home naloxone program for at-risk opioid users. Annals of Emergency Medicine (2016) 69 (3) 340-346

Ambrose G, Amlani A, Buxton JA. Predictors of seeking emergency medical help during overdose events in a provincial naloxone distribution program: a retrospective analysis. BMJ open (2016) 6(6) e011224 http://bmjopen.bmj.com/content/6/6/e011224.full?keytype=ref&ijkey=RicqN3jtsVVMDVt (PI)

Otterstatter M, Amlani A, Guan H, Richardson L. Buxton JA Illicit drug overdose deaths resulting from income assistance payments: Analysis of the ‘check effect’ using daily mortality data. Int J Drug Policy 2016 http://www.ijdp.org/article/S0955-3959(16)30164-5/pdf (PI)

Greer AM, Luchenski SA, Amlani A, Lacroix K, Burmeister C, Buxton JA. Peer engagement in harm reduction strategies and services: a critical case study and evaluation framework from British Columbia, Canada. BMC Public Health (2016)16:452 http://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-016-3136-4 (PI)

Habib A-R, Javer A, Buxton JA. A population-based study investigating chronic rhinosinusitis and the incidence of asthma. The Laryngoscope (2016) 126(6):1296-302

Deonarine A, Amlani A, Ambrose G, Buxton JA. Qualitative assessment of take-home-naloxone program participant and law enforcement interactions in British Columbia. Harm Reduction Journal (2016) 13:17 http://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-016-0106-1 (PI)

Lake S, Kerr T, Buxton J, Guillemi S, Parashar S, Montaner J, Wood E, Milloy MJ. Prescription opioid injection among HIV-positive people who inject drugs in a Canadian setting. AIDS and Behaviour (2016) 20(12):2941-2949

Johnson C, Buxton J, Harrison S, Ahamad K, Nolan S, Lappalainen L, Mead A, McLean M, Wood E. Implementation of a  naloxone distribution program in an inpatient addiction service: A case study Canadian Journal of Addiction (2016) 7(1) 22-25

Greer A, Hu S, Amlani A, Moreheart S, Sampson O, Buxton JA, Patient perspectives of methadone formulation change in British Columbia, Canada: outcomes of a provincial survey. SATPP (2016) 11:3 http://substanceabusepolicy.biomedcentral.com/articles/10.1186/s13011-016-0048-3 (PI)


Young MM, Pirie T, Buxton JA, Hosein S. The Rise of Overdose Deaths Involving Fentanyl and the Value of Early Warning. Canadian Journal of Addiction (2015) 6(3)13-17 http://www.csam-smca.org/wp-content/uploads/2015/12/CSAM-December2015.pdf

Harris J, Martin RE, Filek H, Macaulay AC, Buxton JA, Buchanan M, Korchinski M, Moravan V,  Ramsden V. Familial support impacts incarcerated women’s housing stability. Housing Care and Support (2015) 18(3/4) 80-88

Amlani A, McKee G, Khamis N, Raghukumar G, Tsang E, Buxton JA. Why the FUSS? Fentanyl Urine Screen Study (FUSS) to characterize an emerging threat to people who use drugs in British Columbia, Canada. Harm Reduction Journal (2015) 12(1):54 http://www.harmreductionjournal.com/content/12/1/54 (PI)

Ti, L; Milloy, M-J; Buxton J, McNeil R, Dobrer S, Hayashi K, Wood E, Kerr T. Factors associated with leaving hospital against medical advice among people who use illicit drugs in Vancouver, Canada. PLoS ONE (2015) 10(10) e0141594 http://www.ncbi.nlm.nih.gov/pubmed/26509447

Lake S, Hayashi K, Buxton J, Milloy M-J, Dong H, Wood E, Montaner J, Kerr T.  The effect of prescription opioid injection on the risk of non-fatal overdose among people who inject drugs. Drug Alcohol Depend. (2015) 156:297-303

Tozer K, Tzemis D, Amlani A, Coser L, Taylor D, Van Borek N, Saewyc E, Buxton JA. Reorienting risk to resilience: Street involved youth perspectives on preventing transition to injection drug use BMC Public Health (2015) (PI) http://www.biomedcentral.com/1471-2458/15/800

Baljak Y, Greer AM, Amlani A, Sampson O, Buxton JA. Drug quality assessment practices and communication of drug alerts among people who use drugs. Int J Drug Policy (2015) 26(12) 1251-7 (PI)

Buxton JA, Omura J, Kuo M, Ross C, Tzemis D, Purssell R, Gardy J, Carleton B. Genetic determinants of cocaine-associated agranulocytosis. BMC Res Notes (2015)  8:240 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467676/ (PI)

Kuo ME, Janjua NZ, Burchell AN, Buxton JA, Krajden M, Gilbert M. Decreasing hepatitis C incidence among a population of repeat anti-HCV testers, British Columbia, Canada, 1993-2011. AJPH (2015) Jun 11:e1-e7

Wong J, Moore D, Kanters S, Michelow W, Buxton J, Robert W, Gustafson R, Hogg R, Ogunnaike-Cooke S, Wong T, Gilbert M,  the ManCount Study Team. Seroprevalence and correlates of Hepatitis C seropostivity among men who have sex with men (MSM) in Vancouver, British Columbia (BC): A cross-sectional survey. Sexually Transmitted Infections (2015) 91(6):430-3

Jafari S, Buxton JA, Joe R. Rising fentanyl-related overdose deaths in BC. Canadian Journal of Addiction (2015) 6(1)4-6 http://www.csam-smca.org/wp-content/uploads/2015/04/CJA-vol6-no1-2015.pdf

Siegel J, Yassi A, Rau A, Buxton JA, Wouters E, Engelbrecht MC, Uebel KE, Nophale LE. Workplace interventions to reduce HIV and TB stigma among healthcare workers- where do we go from here? Global Public Health (2015) 1-13

Ti L, Buxton J, Harrison S, Dobrer S, Montana J, Wood E, Kerr T. Willingness to accept an in-hospital supervised injection facility among hospitalized people who use illicit drugs. Journal of Hospital Medicine (2015) 10(5) 301-306

Nicol JJE, Yarema MC, Jones GR, Martz W, Purssell RA, MacDonald JC, Wishart I, Durigon M, Tzemis D, Buxton JA. Deaths from exposure to Paramethoxymethamphetamine in Alberta and British Columbia, Canada: a case series. CMAJ open (2015). 3(1) E83-90 http://www.cmajopen.ca/content/3/1/E83.full.pdf+html

Lake S, Wood E, Buxton J, Dong H, Montaner J, Kerr T. Prescription opioid use and non-fatal overdose in a cohort of injection of drug users. American Journal of Drug and Alcohol Abuse. (2015) 41(3):257-63

Select publications 2014 and earlier

Kuo M, Shamsian A, Tzemis D, Buxton JA A drug use survey among clients of harm reduction sites across British Columbia, Canada, 2012.Harm Reduction Journal  (2014) 11:13 http://www.harmreductionjournal.com/content/11/1/13

Coser LR, Tozer K, Van Borek N, Tzemis D, Taylor D, Saewyc E,  Buxton JA, Finding a Voice: Participatory Research with Street-Involved Youth in the Youth Injection Prevention (YIP) Project.  Health Promotion Practice (2014) (2014) 15(5):732-8   

Tzemis D, Campbell J, Kuo M, HRSS committee, Buxton JA. A cross-sectional study of public attitudes towards safer drug use practices in British Columbia, Canada. Substance Abuse Treatment, Prevention, and Policy  (2013) 8:40  

Crabtree A, Mercer G, Horan R, Grant S, Tan T, Buxton J.  A qualitative study of the perceived effects of blue lights in washrooms on people who use injection drugs.  Harm Reduction Journal (2013) 10:22  

Buxton JA, McIntyre CC, Tu AW, Eadie B, Remple VP, Halperin B, Pielak KL. Who knows more about immunization: A survey of public health nurses and physicians? Canadian Family Physician (2013) 59: e514-e52

Persaud S. Tzemis T, Kuo M, Bungay V, Buxton JA. Controlling Chaos: the perceptions of crack cocaine users in Vancouver. Journal of Addiction, 2013 Article ID 851840  

Brunings P, Klar SA, Butt G, Nijkamp MD, Buxton JA. “It’s a big part of our lives.” Defining quality of hepatitis C care from patient’s perspective: A qualitative study.” Gastroenterology Nursing (2013) 36(4)249-257  

Taylor D, Masse LC, Ho A, Rekart ML, Tyndall M, Henry B, Clifton J, Peters L, Ogilvie G, Buxton JA. A brief tool to assess capacity to consent for medical care among homeless individuals with problematic substance use: Study protocol. Archives of Public Health (2013) 71:11

Stockwell T, Zhao J, Martin G, Macdonald S, Vallance K, Treno A. Ponicki WR, Tu A, Buxton J. Minimum alcohol prices and outlet densities in British Columbia, Canada: Estimated impacts on alcohol attributable hospital admissions. Am J Public Health (2013) 103(11):2014-20  http://ajph.aphapublications.org/doi/pdf/10.2105/AJPH.2013.301289

Bottorff JL, Bissell LJL, Balneaves LG, Oliffe JL, Capler R, Buxton J. Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study. Harm Reduction Journal (2013) 10 (1): 2 DOI: 10.1186/1477-7517-10-2

Zhao J, Stockwell T, Martin G, Macdonald S, Vallance K, Treno A. Ponicki WR, Tu A, Buxton J. The relationship between changes to minimum alcohol prices, outlet density and alcohol-attributable deaths in British Columbia, 2002-2009. Addiction (2013) 108(6):1059-69

Ti L,Tzemis D, Buxton JA. Peer engagement in the context of policy and program development: A review of the literature Substance Abuse Treatment, Prevention, and Policy (2012) 7:47  http://www.substanceabusepolicy.com/content/7/1/47

Funk A, Van Borek N, Taylor D, Grewal P, Tzemis D, Buxton JA. Climbing the ‘Ladder of Participation’: Engaging experiential youth in a participatory research project. CJPH (2012) 103(4) 288-292 http://journal.cpha.ca/index.php/cjph/article/view/3252/2652

Jafari S, Buxton JA Copes R, Baharlou S, Etminan M. Tattooing and risk of hepatitis B: A systematic review and meta-analysis CJPH ( 2012) 103(3) 207-212


Lee J, Buxton JA BC Harm Reduction Strategies and Services Committee. Policy Indicators Report. Data to December 31st 2016. August 2017 https://towardtheheart.com/resource/hrss-indicators-report/open

Greer, A.G., Amlani, A.A., Buxton, J.A. & the PEEP team. Peer Engagement Best Practices: A Guide for Health Authorities and other providers. (2016) Vancouver, BC. BCCDC http://www.bccdc.ca/resource-gallery/Documents/PEEP%20Best%20Practice%20Guidelines.pdf

Klassen D, Buxton JA. Overdose recognition and response in the BC Take home naloxone program. Review of data to July 2016. (2016) Vancouver, BC. BCCDC http://www.bccdc.ca/resource-gallery/Documents/Educational%20Materials/Epid/Other/THN%20report%20Aug_final.pdf

Davis A, Amlani A, Buxton JA. Substance use trends in BC: A survey of harm reduction clients. Overall results for British Columbia: 2015. Vancouver, BC. BCCDC http://www.bccdc.ca/resource-gallery/Documents/Educational%20Materials/Epid/Other/2015_Report_July%204_LATEST.pdf

Greer, A.M. & Buxton, J.A. (2016). A guide for paying peer research assistants. Vancouver, BC: BCCDC  http://www.bccdc.ca/resource-gallery/Documents/A%20guide%20for%20paying%20peer%20research%20assistants%202017.pdf

Ambrose G, Buxton J. Overdose recognition and response in the BC take home naloxone program. Review of data Sep 2012-Mar 2015. (Sep 2015) http://towardtheheart.com/assets/naloxone/evaluation-of-bc-thn-sep15_181.pdf

Sorge J, Buxton J, Amlani A, Ishiguro S. Substance use trends in BC: A survey of harm reduction clients.2014 (2015) http://www.bccdc.ca/health-professionals/clinical-resources/harm-reduction/substance-use-trends Reports for 2012 and 2013 also available on this page.

Kling, Rakel N; Baljak, Yuko; Amlani, Ashraf; Alissa Greer Buxton, Jane. Perceptions of Adulteration and Quality Assurance Practices Reported by People who Use Drugs: A Review of the Literature http://www.bccdc.ca/health-professionals/clinical-resources/harm-reduction/communicating-drug-alerts

Tanner Z, Matsukura M, Ivkov V, Amlani A, Buxton JA. British Columbia Drug Overdose and Alert Partnership report. BC Drug Use Epidemiology (September 2014) BCCDC http://www.bccdc.ca/NR/rdonlyres/360E0050-F939-4C0E-B627-854F0A7B346D/0/FinalDOAPReport2014.pdf

Best practice recommendations for Canadian Harm reduction programs that provide service to people who use drugs and are at risk for HIV, HCV and other harms http://www.catie.ca/sites/default/files/BestPracticeRecommendations_HarmReductionProgramsCanada_Part1_August_15_2013.pdf

Decreasing HIV infections among people who use drugs by injection in British Columbia: Potential explanations an recommendations for further action. Report from the Office of the Provincial Health officer March 2011. Prepared by Gilbert M, Buxton J Tupper K. http://www.bccdc.ca/NR/rdonlyres/01022E62-AFC3-46AD-87EF-17214DEB164E/0/decreasingHIVinIDUpopulation.pdf

Buxton JA, Haden M, Mathias RG. The Regulation of Currently Illegal Drugs. In Encyclopedia of Public Health; (2008) Kirch W (Ed) publisher Springer( 2008) ISBN: 978-1-4020-5613-0

Buxton JA. Young women and methamphetamine use. Chapter 6 in Highs and Lows: Women and substance use; Karen Gelb (Ed) Julia Greenbaum, publisher Centre for Addiction and Mental Health (2007)

SPPH 505 Scientific Basis for Epidemiological Thinking
SPPH 508 Master of Public Health Practicum


Co-instruct Vancouver Summer Program Public Health course

MD Undergraduate Program public health theme lead 

Regular invited guest speaker


SPPH 515 (standard and DL) Surveillance of illegal drug use
SPPH 520 (standard and DL) Bloodborne pathogens
SPPH 540 (standard and DL) Evaluation of BC harm reduction program

Graduate Student(s)

Post Doc: Ehsan Jozaghi, SPPH


Rielle Capler,  Interdisciplinary Studies
Alissa Greer,  Interdisciplinary Studies

Pauline Voon, SPPH

Stephanie Lake, SPPH

Andreas Pilarinos,  Interdisciplinary Studies

Kate McLeod, SPPH

Mohammad Karamouzian , SPPH

Committee member
Andrea Jones, MD/PhD

Harm reduction and illegal drug use epidemiology and knowledge translation
Hepatitis A, B and C, and bloodborne pathogens
Prison health participatory research
Knowledge, attitudes and behaviours regarding immunization

Evaluation and research within the harm reduction program:

  • Evaluation of the take home naloxone program in BC
  • Public Knowledge and attitudes regarding harm reduction
  • Survey of drug use and risk behaviours of people who use harm reduction distribution sites

Mortality and morbidity attributable to Alcohol, illegal drugs and tobacco using administrative data and attributable fraction methodology

Participatory prison research- HIV prevention and cancer screening
Harm reduction initiatives for people who use illicit alcohol
Knowledge synthesis methadone maintenance therapy retention

Research grants:

  • Peter wall Institute for Advanced Studies. Co-PI Bonding through Bars – protecting the health and bond of incarcerated mothers and their children.
  • Vancouver Foundation: PI: Preventing the transition of at risk youth into injection drug use

Co-I CIHR grants

  • CIHR; Cross Canada best practice recommendations for harm reduction programs
  • CIHR; Participatory prison community based HIV – prevention project
  • PHAC Participatory approach to improving cancer screening and early detection among formerly incarcerated individuals